If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Masachika Fujiyoshi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Cholesterol Medicine & Life Sciences
Cytochrome P-450 CYP3A Medicine & Life Sciences
ATP-Binding Cassette Transporters Medicine & Life Sciences
Blood-Brain Barrier Medicine & Life Sciences
Choroid Plexus Medicine & Life Sciences
IDL Lipoproteins Medicine & Life Sciences
Messenger RNA Medicine & Life Sciences
Low Density Lipoprotein Receptor-Related Protein-1 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 134 Citations
  • 4 h-Index
  • 11 Article

Clinical pharmacokinetics of oral azithromycin in epididymal tissue

Sadahira, T., Wada, K., Ikawa, K., Morikawa, N., Mitsui, M., Araki, M., Fujiyoshi, M., Ishii, A., Watanabe, M., Watanabe, T. & Nasu, Y., Jan 1 2019, In : Journal of Infection and Chemotherapy.

Research output: Contribution to journalArticle

Azithromycin
Pharmacokinetics
Epididymitis
Chlamydia trachomatis
Orchiectomy

Dasatinib can Impair Left Ventricular Mechanical Function But May Lack Proarrhythmic Effect: A Proposal of Non-clinical Guidance for Predicting Clinical Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors

Izumi-Nakaseko, H., Fujiyoshi, M., Hagiwara-Nagasawa, M., Goto, A., Chiba, K., Kambayashi, R., Naito, A. T., Ando, K., Kanda, Y., Ishii, I. & Sugiyama, A., Jan 1 2019, In : Cardiovascular Toxicology.

Research output: Contribution to journalArticle

Left Ventricular Function
Protein-Tyrosine Kinases
Induced Pluripotent Stem Cells
Dogs
Stem cells

Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir

Matsumoto, J., San, S. N., Fujiyoshi, M., Kawauchi, A., Chiba, N., Tagai, R., Sanbe, R., Yanaka, S., Sakaue, H., Kato, Y., Nakamura, H., Yamada, H. & Ariyoshi, N., Jan 1 2019, (Accepted/In press) In : Journal of Human Genetics.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP3A
Antiviral Agents
8-cyclohexyl-N-((dimethylamino)sulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)cycloprop(d)indolo(2,1-a)(2)benzazepine-5-carboxamide
In Vitro Techniques
BMS-790052
1 Citation (Scopus)

Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro

San, S. N., Matsumoto, J., Saito, Y., Koike, M., Sakaue, H., Kato, Y., Fujiyoshi, M., Ariyoshi, N. & Yamada, H., Jan 1 2018, (Accepted/In press) In : Xenobiotica.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP3A
Hepatitis C
Protease Inhibitors
Metabolism
Liver Microsomes
3 Citations (Scopus)

The effect of cholesterol overload on mouse kidney and kidney-derived cells

Honzumi, S., Takeuchi, M., Kurihara, M., Fujiyoshi, M., Uchida, M., Watanabe, K., Suzuki, T. & Ishii, I., Oct 15 2018, In : Renal Failure. 40, 1, p. 43-50 8 p.

Research output: Contribution to journalArticle

Low Density Lipoprotein Receptor-Related Protein-2
Cholesterol
Kidney
IDL Lipoproteins
Cell Proliferation